227 Results

People

  1. Motzer
    Motzer
  2. Scher
    Scher
  3. Amar
    Amar
  4. Norton
    Norton
  5. Kris
    Kris
  6. Morris
    Morris
  7. Mulhall
    Mulhall
  8. Papanicolaou
    Papanicolaou
  9. Tap
    Tap
  10. Aghajanian
    Aghajanian

Groups

  1. Department of Medicine (128)
  2. Solid Tumor Oncology Division (97)
  3. Surgery (34)
  4. Survivorship Research (33)
  5. Genitourinary Oncology Service (27)
  6. Division of Subspecialty Medicine (23)
  7. Population Sciences Research Program (20)
  8. Epidemiology and Biostatistics (18)
  9. Hematologic Malignancies, Division of (18)
  10. Breast Medicine Service (17)
  1. "double blind procedure"
Formats
  1. Journal Article (219)
  2. Conference Paper (3)
  3. Correspondence (3)
  4. Editorial (1)
  5. Review (1)
Groups
  1. Department of Medicine (128)
  2. Solid Tumor Oncology Division (97)
  3. Surgery (34)
  4. Survivorship Research (33)
  5. Genitourinary Oncology Service (27)
  6. Division of Subspecialty Medicine (23)

More Groups

People
  1. Howard Scher (10)
  2. Robert Motzer (10)
  3. David Amar (7)
  4. Jose Baselga (7)
  5. Larry Norton (7)
  6. Genovefa Papanicolaou (6)

More People

Years
  1. 2025 (4)
  2. 2024 (21)
  3. 2023 (13)
  4. 2022 (12)
  5. 2021 (5)
  6. 2020 (10)

More Years

Publications
  1. Journal of Clinical Oncology (21)
  2. Lancet Oncology (20)
  3. New England Journal of Medicine (17)
  4. Clinical Cancer Research (9)
  5. Lancet (8)
  6. Annals of Oncology (6)

More Publications

Publishers
  1. Elsevier Science, Inc. (37)
  2. Elsevier Inc. (28)
  3. American Society of Clinical Oncology (21)
  4. Oxford University Press (19)
  5. Lippincott Williams & Wilkins (17)
  6. Massachusetts Medical Society (17)

More Publishers

Results (227)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • A randomized, double-blind, placebo-controlled phase 3 trial of oral brincidofovir for cytomegalovirus prophylaxis in allogeneic hematopoietic cell transplantation
    Journal Article

    Marty, F. M.; Winston, D. J.; Chemaly, R. F.; Mullane, K. M.; Shore, T. B.; Papanicolaou, G. A.; Chittick, G.; Brundage, T. M.; Wilson, C.; Morrison, M. E.; more...
    Biology of Blood and Marrow Transplantation (2019)

    Fulltext@MSK | Save
  • Randomized phase II trial of bevacizumab plus everolimus versus bevacizumab alone for recurrent or persistent ovarian, fallopian tube or peritoneal carcinoma: An NRG Oncology/Gynecologic Oncology Group study
    Journal Article

    Tew, W. P.; Sill, M. W.; Walker, J. L.; Secord, A. A.; Bonebrake, A. J.; Schilder, J. M.; Stuckey, A.; Rice, L.; Tewari, K. S.; Aghajanian, C. A.
    Gynecologic Oncology (2018)

    Fulltext@MSK | Save
  • Nivolumab plus ipilimumab or nivolumab alone versus ipilimumab alone in advanced melanoma (CheckMate 067): 4-year outcomes of a multicentre, randomised, phase 3 trial
    Journal Article

    Hodi, F. S.; Chiarion-Sileni, V.; Gonzalez, R.; Grob, J. J.; Rutkowski, P.; Cowey, C. L.; Lao, C. D.; Schadendorf, D.; Wagstaff, J.; Dummer, R.; more...
    Lancet Oncology (2018)

    Fulltext@MSK | Save
  • Trifluridine/tipiracil versus placebo in patients with heavily pretreated metastatic gastric cancer (TAGS): A randomised, double-blind, placebo-controlled, phase 3 trial
    Journal Article

    Shitara, K.; Doi, T.; Dvorkin, M.; Mansoor, W.; Arkenau, H. T.; Prokharau, A.; Alsina, M.; Ghidini, M.; Faustino, C.; Gorbunova, V.; more...
    Lancet Oncology (2018)

    Fulltext@MSK | Save
  • Intraoperative ketamine for prevention of depressive symptoms after major surgery in older adults: An international, multicentre, double-blind, randomised clinical trial
    Journal Article

    Mashour, G. A.; Ben Abdallah, A.; Pryor, K. O.; El-Gabalawy, R.; Vlisides, P. E.; Jacobsohn, E.; Lenze, E.; Maybrier, H. R.; Veselis, R. A.; Avidan, M. S.; more...
    British Journal of Anaesthesia (2018)

    Fulltext@MSK | Save
  • Cabozantinib in patients with advanced and progressing hepatocellular carcinoma
    Journal Article

    Abou-Alfa, G. K.; Meyer, T.; Cheng, A. L.; El-Khoueiry, A. B.; Rimassa, L.; Ryoo, B. Y.; Cicin, I.; Merle, P.; Chen, Y.; Park, J. W.; more...
    New England Journal of Medicine (2018)

    Fulltext@MSK | Save
  • Inactivated varicella zoster vaccine in autologous haemopoietic stem-cell transplant recipients: An international, multicentre, randomised, double-blind, placebo-controlled trial
    Journal Article

    Winston, D. J.; Mullane, K. M.; Cornely, O. A.; Boeckh, M. J.; Brown, J. W.; Pergam, S. A.; Trociukas, I.; Žák, P.; Craig, M. D.; Papanicolaou, G. A.; more...
    Lancet (2018)

    Fulltext@MSK | Save
  • Radiographic progression-free survival as a clinically meaningful end point in metastatic castration-resistant prostate cancer: The PREVAIL randomized clinical trial
    Journal Article

    Rathkopf, D. E.; Beer, T. M.; Loriot, Y.; Higano, C. S.; Armstrong, A. J.; Sternberg, C. N.; De Bono, J. S.; Tombal, B.; Parli, T.; Bhattacharya, S.; more...
    JAMA Oncology (2018)

    Fulltext@MSK | Save
  • Peptidomimetic blockade of MYB in acute myeloid leukemia
    Journal Article

    Ramaswamy, K.; Forbes, L.; Minuesa, G.; Gindin, T.; Brown, F.; Kharas, M. G.; Krivtsov, A. V.; Armstrong, S. A.; Still, E.; de Stanchina, E.; more...
    Nature Communications (2018)

    Fulltext@MSK | Save
  • A randomized, double-blind, placebo-controlled phase II study of the efficacy and safety of monotherapy ontuxizumab (MORAb-004) plus best supportive care in patients with chemorefractory metastatic colorectal cancer
    Journal Article

    Grothey, A.; Strosberg, J. R.; Renfro, L. A.; Hurwitz, H. I.; Marshall, J. L.; Safran, H.; Guarino, M. J.; Kim, G. P.; Hecht, J. R.; Weil, S. C.; more...
    Clinical Cancer Research (2018)

    Fulltext@MSK | Save